A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation

Iacono, A., Terrin, M., Rajakopal, K., McGrain, J., Barr, E., Rinaldi, J., … Pham, S. (2016). A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation. The Journal of Heart and Lung Transplantation, 35(4), S44–S45. https://doi.org/10.1016/j.healun.2016.01.120